Advertisement

Shares of Hansen Medical are down after the medical device company reported wider 2012 losses and declines to issue guidance for 2013.

Hansen Medical

Hansen Medical (NSDQ:HNSN) managed to eke out a profit during the 4th quarter on the sale and licensing of some of its patents, but still posted wider losses for 2012, sending shares down YY% on Wall Street last week.

The Mountain View, Calif.-based medical device company reported profits of $9.6 million, or 15¢ per share, on sales of $4.3 million during the 3 months ended Dec. 31, 2012, for a top-line slide of 29.6% compared with Q4 2011, when Hansen posted losses of $9.5 million.

For the full year Hansen logged losses of $22.1 million, or 35¢ per share, on sales of $17.6 million, for a 32.5% widening of losses and a 20.3% sales slide.

Advertisement
Advertisement